Headaches and women: treatment of the pregnant and lactating migraineur

Headache. Nov-Dec 1993;33(10):533-40. doi: 10.1111/j.1526-4610.1993.hed3310533.x.

Abstract

Migraine is a hormonally sensitive episodic headache disorder which may worsen during the first trimester, but usually improves during later pregnancy. Its treatment can be difficult because of the risks of injury to the fetus and newborn. These risks include teratogenicity, embryo mortality, fetal growth abnormalities, and perinatal effect. This paper reviews the effects of drugs on the fetus and newborn, their FDA classification, and their use during both pregnancy and lactation. Specific recommendations are given.

Publication types

  • Review

MeSH terms

  • Analgesics / adverse effects*
  • Analgesics / therapeutic use
  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use
  • Breast Feeding*
  • Ergotamine / adverse effects
  • Ergotamine / therapeutic use
  • Female
  • Humans
  • Hypnotics and Sedatives / adverse effects
  • Hypnotics and Sedatives / therapeutic use
  • Migraine Disorders / drug therapy*
  • Migraine Disorders / physiopathology
  • Pregnancy
  • Pregnancy Complications / drug therapy*
  • Pregnancy Complications / physiopathology
  • Risk Factors

Substances

  • Analgesics
  • Antipsychotic Agents
  • Hypnotics and Sedatives
  • Ergotamine